Gujarat Terce Laboratories Limited

BSE:524314 Stok Raporu

Piyasa değeri: ₹680.3m

Gujarat Terce Laboratories Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Gujarat Terce Laboratories has a total shareholder equity of ₹88.6M and total debt of ₹39.4M, which brings its debt-to-equity ratio to 44.5%. Its total assets and total liabilities are ₹248.4M and ₹159.8M respectively. Gujarat Terce Laboratories's EBIT is ₹32.2M making its interest coverage ratio 14.5. It has cash and short-term investments of ₹948.0K.

Anahtar bilgiler

44.5%

Borç/özkaynak oranı

₹39.43m

Borç

Faiz karşılama oranı14.5x
Nakit₹948.00k
Eşitlik₹88.61m
Toplam yükümlülükler₹159.78m
Toplam varlıklar₹248.39m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 524314's short term assets (₹131.3M) exceed its short term liabilities (₹106.4M).

Uzun Vadeli Yükümlülükler: 524314's short term assets (₹131.3M) exceed its long term liabilities (₹53.4M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 524314's net debt to equity ratio (43.4%) is considered high.

Borcun Azaltılması: 524314's debt to equity ratio has increased from 19.6% to 44.5% over the past 5 years.

Borç Kapsamı: 524314's debt is well covered by operating cash flow (32.7%).

Faiz Kapsamı: 524314's interest payments on its debt are well covered by EBIT (14.5x coverage).


Bilanço


Sağlıklı şirketleri keşfedin